Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
2008 Science
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
2013 Standout
Stem Cell–Derived Culture Models of Hepatitis E Virus Infection
2018 StandoutNobel
Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III.
1991
Homocysteine and vascular disease
1999 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Lipoprotein(a) Levels and Risk of Coronary Heart Disease in Men
1994
Lyme neuroborreliosis—epidemiology, diagnosis and management
2015
Copper supplementation of adult men: Effects on blood copper enzyme activities and indicators of cardiovascular disease risk
1997
Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD
1998
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2010 Standout
Coronary artery disease is highly prevalent among patients with premature peripheral vascular disease
1994
Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis
1997
The metabolic syndrome
2010 Standout
Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: The muscatine study
1996 Standout
Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy
2010
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Cardiac calcification in adult hemodialysis patients
2002 Standout
Lipoprotein(a): relation to other risk factors and genetic heritability. Results from a Dutch parent-twin study
1993
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
1995 Standout
Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.
1994
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Suppression of lung adenocarcinoma progression by Nkx2-1
2011 Nature
The metabolic syndrome
2005 Standout
Methods of assessment of iodine status in humans: a systematic review
2009 Standout
Homocysteine and Risk of Ischemic Heart Disease and Stroke
2002 Standout
The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?
2004
MicroRNA biogenesis pathways in cancer
2015 Standout
Influence of plasma lipoprotein(a) levels on coronary vasomotor response to acetylcholine
1995
EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis
2009
Dietarytrans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women
1994
Does Lipoprotein(a) Impair Endothelial Function?
1998
Gene Transfer of Cytidine Deaminase apoBEC-1 Lowers Lipoprotein(a) in Transgenic Mice and Induces Apolipoprotein B Editing in Rabbits
1996
Emerging Biological Principles of Metastasis
2017 Standout
Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
1993
Impact of Apolipoprotein(a) Phenotypes on Long-Term Renal Transplant Survival
2001
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
2005
Differential Regulation of Lipoprotein and Hepatitis C Virus Secretion by Rab1b
2017 StandoutNobel
Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis
2000
Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
2000
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
1999
Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials
2003 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Atherosclerosis
2000 StandoutNature
The Human Plasma Proteome
2002 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects
1997
C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients
2006
Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents
2003
Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study
1994
Lyme borreliosis
2011 Standout
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Homocysteine and Atherothrombosis
1998 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Fingerprinting food: current technologies for the detection of food adulteration and contamination
2012 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease
1997 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
Both dietary 18:2 and 16:0 may be required to improve the serum LDL/HDL cholesterol ratio in normocholesterolemic men
1995
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Air Pollution and Cardiovascular Disease
2004 Standout
Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors
2006 Standout
Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients.
1997
Tocopherols and total phenolics in 10 different nut types
2005 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Intrahepatic Role of Exchangeable Apolipoproteins in Lipoprotein Assembly and Secretion
2012
Evaluating non-randomised intervention studies
2003 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Effects of canola, corn, and olive oils on fasting and postprandial plasma lipoproteins in humans as part of a National Cholesterol Education Program Step 2 diet.
1993
Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen
1999
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders
2003
Fatty acid, tocopherol and sterol content of some hazelnut varieties (Corylus avellana L.) harvested in Oregon (USA)
1998
Relationship Between Plasma Viscosity and the Severity of Coronary Heart Disease
1998
Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans.
1992
Role of ApoCs in Lipoprotein Metabolism
1999
Measurement of Organ-Specific and Acute-Phase Blood Protein Levels in Early Lyme Disease
2019 StandoutNobel
Plasma Concentration of Lipoprotein(a) and the Risk of Future Stroke
1995
Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.
1990
Suppression of non-small cell lung tumor development by the let-7 microRNA family
2008
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Lipoprotein(a): resurrected by genetics
2012
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
1993 Standout
Low Expression of the Apolipoprotein B mRNA–Editing Transgene in Mice Reduces LDL Levels but Does Not Cause Liver Dysplasia or Tumors
1998 StandoutNobel
A Prospective Study of Lipoprotein(a) and the Risk of Myocardial Infarction
1993
Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men.
1994
The Effect of Select Nutrients on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels
2005
Works of M. Sandkamp being referenced
A novel lymphocyte transformation test (LTT-MELISA®) for Lyme borreliosis
2006
HMGA2 overexpression in non‐small cell lung cancer
2007
Comparative effects of a recommended lipid-lowering diet vs a diet rich in monounsaturated fatty acids on serum lipid profiles in healthy young adults
1992
Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.
1991
Simplified Turbidimetric Determination of Apolipoproteins A-I, A-II and B Using a Microtitre Method
1988
Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age
1990
LTT-MELISA is clinically relevant for detecting and monitoring metal sensitivity.
2006
Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population
1991
Dose-Response Relationships of Serum Lipid Measurements With the Extent of Coronary Stenosis
1995